Clinical Trial

Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury

Completed
View on ClinicalTrials.gov →
Summary
Recent observational data point towards a reduced incidence of acute kidney injury (AKI) with early caffeine use, but high-quality randomized controlled trials comparing early caffeine initiation to supportive therapy alone are lacking. This study aims to fill this critical gap by comparing the efficacy of early caffeine administration versus supportive therapy in preventing AKI in preterm neonates.
Protocol Amendment History 1 change
critical Trial completed 2026-05-23
Trial Details
NCT Number NCT07305935
Lead Sponsor Muhammad Aamir Latif
Conditions Preterm Birth
Enrollment 236 participants
Start Date 2025-10-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22